Foundry Partners’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-10,600
Closed -$67K 457
2016
Q3
$67K Sell
10,600
-7,275
-41% -$46K ﹤0.01% 371
2016
Q2
$75K Hold
17,875
﹤0.01% 365
2016
Q1
$78K Buy
+17,875
New +$78K 0.01% 266